Publications 2002
- Age, Health and the Willingness to Pay for Mortality Risk Reductions: a Contingent Valuation Survey of Ontario Residents. Journal of Risk and Uncertainty 2002;24(2):161-186. Krupnick A, Alberini A, Cropper M, Simon N, O'Brien B, Goeree R, Heintzelman M.
- Cost-Effectiveness of Tolterodine for Patients With Urge Incontinence Who Discontinue Initial Therapy with Oxybutynin: A Canadian perspective. Clinical Therapeutics, 2001;23(12):2038-2048. O'Brien B, Goeree R, Bernard L, Rosner A, Williamson T.
- Estimation of Confidence Intervals for Cost-Effectiveness When Costs and Effects are Censored. Medical Decision Making, 2002;22(2):173-177. Blackhouse G, Briggs AH, O'Brien BJ.
- Is There a Kink in Consumers' Threshold Value for Cost-Effectiveness in Health Care? Health Economics, 2002;11(2):175-180. O'Brien BJ, Gertsen K, Willan AW, Faulkner L.
- Lung Radiology in the Tropics. Clin Chest Med, 2002;23:309-328. Tshibwabwa E, Richenberg J, Aziz ZA.
- Oseltamivir for Treatment of Influenza in Healthy Adults: Pooled trial evidence and cost-effectiveness model for Canada. Value in Health (forthcoming). O'Brien BJ, Goeree R, Blackhouse G, Smieja M, Loeb M.
- Placebos in Research: Clinical and Ethical Issues. Dated April 18, 2002 (Holbrook, A) PDF
- Probabilistic Analysis of Cost-Effectiveness Models: Choosing between treatment strategies for gastro-esophageal reflux disease. Medical Decision Making 2002;23:377-401. Briggs AH, Goeree R, Blackhouse G, O'Brien B.
- Rapid Increase in Statins Newly-Dispensed to Ontario Seniors Between 1994 and 2000. Canadian Journal of Cardiology, 2002 (forthcoming). Levy AR, O'Brien BJ, McMullen E, May FW, Demers C, Marshall D, MacLeod S.
- Systems for Drug Safety Surveillance: Can (methodologists + realists) = activists? Dated April 2002 (Holbrook, A) PDF
- Thinking Outside the Box: Recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Ann Rev Public Health, 2002;23:377-401. Briggs AH, O'Brien BJ, Blackhouse G.
- The Role of Models within Economic Analysis. Focus on Type 2 diabetes Mellitus. Pharmacoeconomics, 2002;20 (Suppl 1):11-19. Coyle D, Lee KM, O'Brien BJ.
- Use and Mis-use of Cost-Effectiveness Terminology in the Gastroenterology Literature: A systematic review. Am J Gastroenterol, 2002;97(1):172-179. Marshall JK, Cawdron R, Yamamura DL, Ganguli S, Lad R, O'Brien BJ.
